Anatoliy I. Ishchenko

Anatoliy I. Ishchenko

Auto-generated profile, based on publicly available information

Anatoliy I. Ishchenko

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2022 in Gynecological Endocrinology
Verified
Journal Article
Closed access
AUAra Unanyan
Ara Unanyan
LPLaura Pivazyan
Laura Pivazyan
EKEkaterina Krylova
Ekaterina Krylova
AEAndrey Eskin
Andrey Eskin
AZAraksya Zakaryan
Araksya Zakaryan
AIAnatoly Ishchenko
Anatoly Ishchenko
Our study aims to compare the effect of metformin, inositol and their combinations on the efficiency in improving outcomes of assisted reproductive technologies in women with PCOS.PubMed, The Cochr...

14 May 2020 in Creative surgery and oncology
Verified
Journal Article
Open access
PDF file
AIA. I. Ishchenko
A. I. Ishchenko
AYA. G. Yashchuk
A. G. Yashchuk
AMA. V. Murashko
A. V. Murashko
YCYu. V. Chushkov
Yu. V. Chushkov
IMI. I. Musin
I. I. Musin
ABA. A. Biryukov
A. A. Biryukov
Органосохраняющие операции на матке при врастании плаценты: клинический опыт

15 December 2017 in V.F.Snegirev Archives of Obstetrics and Gynecology
Verified
Journal Article
Open access
DBDmitry V. Baburin
Dmitry V. Baburin
AUA. L Unanyan
A. L Unanyan
ISI. S Sidorova
I. S Sidorova
EKE. A Kudrina
E. A Kudrina
AIA. I Ishchenko
A. I Ishchenko
The aim of the study is to identify the most significant clinical and anamnestic risk factors for the onset and progression of endometrial hyperplastic processes and the development of malignant transformation of endometrium in women of perimenopausal age, with taking into account their importance on the basis of statistical analysis. Methods. Based on Spearman’s correlation analysis and determination the degree of dependence of the development of endometrial cancer (from 0 to 1) on clinical-anamnestic and diagnostic risk factors (risk ratio (RR) in groups), there were obtained coefficients for a mathematical model allowing with the use of the binary logistic regression method predict the risk of the appearance of endometrial cancer. Results. The most clinically and statistically significant risk factors for the progression of the pathological process of the endometrium, having a high RR (greater than 1) and a confidence interval of 95% (p < 0.05), are (in the order of significance): recurrence of the endometrial hyperplastic process, obesity, the pronounced blood flow in Ultrasound with color Doppler mapping, polycystic ovary syndrome, abnormal ovarian formations, infertility (primary and secondary), type 2 diabetes mellitus, combined uterine pathology (myoma and/or adenomyosis), hereditary predisposition to cancer development, hypertension, age of 50 years and older. Conclusion. The tactics of the management and treatment of patients with hyperplastic endometrial processes should be based on the detection of the degree of the risk of the progression of pathological processes and the development of the malignant transformation of the endometrium. The study of the individual prognosis of endometrial cancer in patients with hyperplastic endometrial processes currently is becoming increasingly important due to the need to construct a rational treatment plan of the management and performing the follow-up dispensary observation on the basis of a scientifically justified forecast. Results obtained during our work allowed us identify statistically significant risk factors for the development of endometrial cancer. There were obtained coefficients for the creation a reliable mathematical model. With the use of the method of binary logistic regression, it is possible to calculate the risk of developing cancer and choose an effective management tactic for patients with hyperplastic endometrial processes at the perimenopausal age.

1 January 2025 in Voprosy Ginekologii, Akušerstva i Perinatologii
Verified
Journal Article
Closed access
AIA.I. Ishchenko
A.I. Ishchenko
TDT.A. Dzhibladze
T.A. Dzhibladze
ADA.I. Davydov
A.I. Davydov
IKI.D. Khokhlova
I.D. Khokhlova
VZV.M. Zuev
V.M. Zuev
ASA.A. Siordiya
A.A. Siordiya
The last decade has been marked by the introduction of artificial intelligence (AI) into medical science and practice and, in particular, into obstetrics and gynecology. Due to its ability to learn, high-performance computing and improved image quality as a result of current imaging technologies, AI can provide effective assistance to specialists in diagnosis, prognosis and monitoring of various diseases, personalized selection of treatment measures, medication development, evaluation of the efficacy of medical care, and detection and analysis of medical errors. Objective. To analyze current scientific publications on the application of AI in obstetrics and gynecology. Materials and methods. A literature search was conducted in Cochrane Library, PubMed/Medline, Embase, Google Scholar, Scopus, and Elibrary databases using the following key words: “artificial intelligence”, “augmented reality”, “pathology in obstetrics and gynecology”, “gynecological malignancies”. The paper includes systematic reviews, meta-analyses, cohort studies, original articles on the application of AI in obstetrics and gynecology published between 1950 and 2024. Results. A total of 81 articles meeting the selection criteria were found, which were analyzed and included in this literature review. Publications on AI in obstetrics and gynecology dominated. There was an overall increase in the number of publications related to AI in obstetrics and gynecology over the last decade. Conclusion. The use of AI in diagnosis, prognosis and monitoring of pathologies in obstetrics and gynecology is a promising, actively developing direction in current medicine, which necessitates further research in this field. Key words: artificial intelligence, machine learning, neural networks, pathology in obstetrics and gynecology, diagnosis, prognosis

1 January 2025 in Voprosy Ginekologii, Akušerstva i Perinatologii
Verified
Journal Article
Closed access
KRK.A. Rossolovskaya
K.A. Rossolovskaya
NTN.S. Trifonova
N.S. Trifonova
AIA.I. Ishchenko
A.I. Ishchenko
IGI.V. Gadaeva
I.V. Gadaeva
EBElizaveta Bragina
Elizaveta Bragina
LSL.G. Spivak
L.G. Spivak
Bacterial vaginosis is a biofilm-related disease. Biofilms increase the resistance of microorganisms to antibiotics, which reduces the efficacy of treatment and contributes to recurrences. Clinical guidelines do not provide options to combat biofilms in the treatment of patients with bacterial vaginosis. Objective. To study the efficacy and safety of enzymatic hydrolysis of the biofilm matrix by bovhyaluronidase azoximer (BA) in bacterial vaginosis. Patients and methods. A comparative analysis of clinical and laboratory characteristics of female patients aged 18 to 45 years with bacterial vaginosis treated with metronidazole monotherapy (control group, n = 35) and a combination of metronidazole and bovhyaluronidase azoximer (BA) (study group, n = 37) was performed. To visualize and evaluate the structure of biofilms, all patients underwent electron microscopic examination of a sample from the posterior vaginal vault epithelium. Results. After treatment, the score according to Amsel’s criteria normalized in 97.3% of patients in the study group and in 54.3% of patients in the control group. Complaints of discharge (2.7% and 20%) and vaginal odor (2.7% and 25.7%), Gardnerella vaginalis growth (5.4% and 22.9%), detection of key cells (2.7% and 5.9%) and coccobacillary flora (2.7% and 23.5%) were significantly less frequent in the study group. According to the results of the Femoflor-16 test, patients in the study group had significantly more lactobacilli and fewer anaerobes. According to electron microscopy, biofilms were initially detected in 95.5% of patients in the study group and in 84.2% of patients in the control group. During treatment, their number did not change in 15 of 19 women in the control group (78.9%). In all patients in the study group (100%, n = 22), they were absent or there was a change in their structure. Conclusion. Electron microscopy in the study of a sample from the posterior vaginal vault epithelium in women with bacterial vaginosis allows us to determine the presence of biofilms and assess their structure. Combination therapy with bovhyaluronidase azoximer destroys the biofilm matrix and promotes the transition of bacteria to the planktonic form, which is accompanied by vaginal microbiome normalization, reduction in the severity of complaints and improvement in laboratory test results. Key words: bacterial biofilms, bacterial vaginosis, bovhyaluronidase azoximer, Longidaza

1 January 2020 in Voprosy Ginekologii, Akušerstva i Perinatologii
Verified
Journal Article
Closed access
EKE.V. Kirakosyan
E.V. Kirakosyan
ALAlexey Lyundup
Alexey Lyundup
LAL.S. Aleksandrov
L.S. Aleksandrov
ADAnna Demchenko
Anna Demchenko
AIA.I. Ishchenko
A.I. Ishchenko
MZM.N. Zholobova
M.N. Zholobova
The review analyses the results of using mesenchymal stem cells (MSCs) to restore fertility. Research works have shown that MSCs have the ability to differentiate into empryonic cells under specific induction conditions, and also when transplanted to gonadal tissue. Most studies were performed on MSCs obtained from bone marrow and the umbilical cord. Promising approaches related to the use of cell therapy have shown their high efficacy in preclinical studies: the infertility models in rats, mice and rabbits resulted in pregnancy after cell therapy. Research in this field is intensive: by now there is information about 11 preclinical and 12 clinical studies. The first results of clinical studies are positive. Clinical studies have been planned and started to determine the effect of MSCs transplantation on management of infertility, and their results, among others, will be decisive for introduction of cell therapy of infertility into clinical practice. The findings are promising, but further clinical research is needed to assess the efficacy and safety of MSCs transplantation for fertility restoration. Key words: infertility, gynaecology, treatment, MSCs, stem cells